Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Leriglitazone for efficacy and safety in adult male subjects with cerebral adrenoleukodystrophy is currently recruiting. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Adrenoleukodystrophy

Drugs mentioned

• Leriglitazone (leriglitazone)

Snippet

Sponsor: Minoryx Therapeutics, S.L. | Conditions: Cerebral Adrenoleukodystrophy (cALD) | Phase 3 | Status: RECRUITING